Dublin, April 17, 2019 (GLOBE NEWSWIRE) -- The "ADME Toxicology Testing Market Analysis Report By Technology (Cell Culture, OMICS Tech), By Application (Systemic Toxicity, Renal Toxicity), By Method, By Region, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global ADME toxicology testing market size is expected to generate a revenue of USD 10.25 billion by 2025, exhibiting a CAGR of 11.4% during the forecast period.

Factors such as increased need to check late-stage drug failures with adoption of more appropriate toxicity testing methods by pharmaceutical companies is expected to aid revenue generation for the market.

Absorption, distribution, metabolism, and excretion (ADME) toxicology testing is used to test toxic reactions caused by molecules in clinical trials on factors and systemic reactions such as chemical, pharmaceutical, and genetic. These toxicology testing procedures help in effective drug development, which limits or prevents toxic reactions to the body when administered. Toxicity levels are decided on the results of a series of tests conducted in near natural conditions, which represent almost real-time reactions between the drug and host.

As of 2017, approximately 43.0% of ADME toxicology testing areas carried out are based on cell culture tech. Cell culture technology is adopted widely owing to advantages such as near natural conditions and accurate results obtained at a cellular level.

These assays are conducted for several types of toxic reactions or systems where toxic reactions might take place. Some of the toxicity tests are systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other toxicities that might result in a living tissue. Advancements in testing methods are underway and this trend is likely to be picked up by many companies developing drug molecules. This will speed up the drug discovery process and boost market growth.

Further key findings from the report suggest:

• The market is driven by increasing ratio of late-stage drug failures, resulting in loss of valuable time and investment for drug development. Growth and increasing adoption of OMICS technology is also expected to boost revenue generation in the coming years
• North America is the largest market for ADME toxicology testing owing to presence of large number of pharmaceutical companies competing for commercial launch of novel molecules
• Developing regions of Asia Pacific and Latin America are set to grow considerably as many multinational and local players are striving to enter the market. They are also looking improve their hold in markets that present innovation and growth opportunities
  

Key Topics Covered:

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market driver Analysis
3.1.1.1 High rate of late stage drug failure
3.1.1.2 Increasing need for novel drug molecules
3.1.1.3 Technological advancements
3.1.2 Market restraint analysis
3.1.2.1 Decreasing investments in drug development
3.2 Penetration & growth prospect mapping
3.3 ADME toxicology testing - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's

Chapter 4 ADME toxicology testing Market: Technology Estimates & Trend Analysis
4.1 ADME toxicology testing market by technology, movement analysis
4.2 Cell Culture Technology
4.3 High Throughput Technology
4.4 Molecular Imaging
4.5 OMICS Technology

Chapter 5 ADME toxicology testing Market: Method Estimates & Trend Analysis
5.1 ADME toxicology testing market: method movement analysis
5.2 Cellular Assay
5.3 Biochemical Assay
5.4 In-Silico Assays
5.5 Ex-Vivo Assays

Chapter 6 ADME toxicology testing Market: Application Estimates & Trend Analysis
6.1 ADME toxicology testing market: application movement analysis
6.2 Systemic Toxicity
6.3 Renal Toxicity
6.4 Hepatotoxicity
6.5 Neurotoxicity
6.6 Other Toxicity

Chapter 7 ADME toxicology testing Market: Regional Outlook
7.1 ADME toxicology testing market share by region, 2017 & 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles

• Thermo Fisher Scientific Inc.
• Promega Corporation
• Agilent Technologies
• Albany Molecular Research Inc.
• Accelrys, Inc., (Dassault Systemes BIOVIA)
• Beckman Coulter, Inc., (Danaher)
• Catalent
• Charles River Laboratories International, Inc.
• Covance, Inc. (LabCorp)
• Eurofins Scientific SE
• General Electric Company (Healthcare)
• Life Technologies Corporation
• Miltenyi Biotec
• Quintiles

For more information about this report visit https://www.researchandmarkets.com/r/j1vdaq

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery